Share
Market Research Report

DRUG AND GENE DELIVERY DEVICES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By ProductSub-retinal Injection Cannula · Extension Tube · Intravenous Catheter · Sterile Insulin Syringe · Pre-filled Syringe · and Infusion Bags
  • By Commercialized DrugsLuxturna · Yescarta · Zolgensma · Kymriah · Provenge · and Strimvelis · By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa
  • Published In26 Mar 2026
  • Report CodeCMI5864
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033

Market Segmentation

  • Global Drug and Gene Delivery Devices Market, By Product (Revenue, USD Th, 2021 - 2033)

    • Sub-retinal Injection Cannula
    • Extension Tube
    • Intravenous Catheter
    • Sterile Insulin Syringe
    • Pre-filled Syringe
    • Infusion Bags
  • Global Drug and Gene Delivery Devices Market, By Commercialized Drugs (Revenue, USD Th, 2021 - 2033)

    • Luxturna (Drug Delivery Devices)
    • Yescarta (Drug Delivery Devices)
    • Zolgensma (Drug Delivery Devices)
    • Kymriah (Drug Delivery Devices)
    • Provenge (Drug Delivery Devices)
    • Strimvelis (Drug Delivery Devices)
  • Regional Insights (Revenue, USD Th, 2021 - 2033)

    • North America
      • U.S.
      • Canada
    • Latin America
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
    • Europe
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • GCC Countries
      • Israel
      • Rest of Middle East
    • Africa
      • South Africa
      • North Africa
      • Central Africa